FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093300 [Registered on: 20/08/2025] Trial Registered Prospectively
Last Modified On: 19/08/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Single Arm Study 
Public Title of Study   Evaluation of an AI system for detecting tuberculosis from chest X-rays at KLE Hospital, Belagavi 
Scientific Title of Study   Evaluating and Refining Al Model for TB Identification from Chest X-rays 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pradeep S Goudar 
Designation  Associate Professor 
Affiliation  KLES Dr. Prabhakar Kore Hospital & Medical Research Centre 
Address  84 room number, X ray department JNMC Campus, Nehru Nagar, Belagavi, Karnataka – 590010, India

Belgaum
KARNATAKA
590010
India 
Phone  07411188888  
Fax    
Email  pradeepsgoudar6543@icloud.com  
 
Details of Contact Person
Scientific Query
 
Name  Noor Fatma 
Designation  CTO 
Affiliation  Easiofy Solutions Pvt Ltd 
Address  I 1607, AVJ HEIGHTS ZETA-1 GREATER NOIDA, Gautam Buddha Nagar, UP -201307

Gautam Buddha Nagar
UTTAR PRADESH
201307
India 
Phone  09958499337  
Fax    
Email  noor.fatma@easiofy.com  
 
Details of Contact Person
Public Query
 
Name  Noor Fatma 
Designation  CTO 
Affiliation  Easiofy Solutions Pvt Ltd 
Address  I 1607, AVJ HEIGHTS ZETA-1 GREATER NOIDA, Gautam Buddha Nagar, UP -201307


UTTAR PRADESH
201307
India 
Phone  09958499337  
Fax    
Email  noor.fatma@easiofy.com  
 
Source of Monetary or Material Support  
Easiofy Solutions Pvt ltd 
 
Primary Sponsor  
Name  Easiofy Solutions Pvt Ltd 
Address  I 1607, AVJ Heights Zeta-1, Greater Noida, Gautam Buddha Nagar, UP -201307 
Type of Sponsor  Other [Pvt Ltd] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pradeep S Goudar  KLES Dr. Prabhakar Kore Hospital & Medical Research Centre  84 room number, X ray department,JNMC Campus, Nehru Nagar, Belagavi, Karnataka – 590010, India
Belgaum
KARNATAKA 
07411188888

pradeepsgoudar6543@icloud.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee of KLE Academy of Higher Education and Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J984||Other disorders of lung,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Standard Radiological Interpretation  Standard diagnostic workflow for suspected TB cases at KLE Hospital. Chest X-rays are interpreted by qualified radiologists, and findings are correlated with confirmatory tests such as High-Resolution CT (HRCT), nucleic acid amplification tests (NAAT e.g., GeneXpert, Truenat), and documented clinical diagnoses. This represents the current standard of care against which the AI model’s performance will be compared. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  Patients who have undergone a chest X-ray as part of their diagnostic evaluation for suspected TB or other respiratory illness within the study period.
Availability of confirmatory test results (e.g., NAAT such as GeneXpert or Truenat, HRCT, or clinical diagnosis).
Complete imaging and clinical records available in the PACS and hospital database. 
 
ExclusionCriteria 
Details  Patients younger than 18 years of age.

Poor-quality chest X-rays (e.g., underexposure, overexposure, excessive motion artifacts, or significant image degradation).

Incomplete imaging records or missing confirmatory test results.

Cases lacking adequate clinical metadata or follow-up information.

Duplicate imaging records of the same episode without added diagnostic value. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Diagnostic accuracy of ImagiXAI-CXR for Active TB detection from chest X-rays, quantified by sensitivity, specificity, PPV, NPV, and AUC, using confirmatory clinical and radiological findings as reference standards, assessed at the time of retrospective analysis.  16 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="1000"
Sample Size from India="1000" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This retrospective observational study at KLE Hospital, Belagavi, aims to evaluate the diagnostic accuracy of ImagiXAI-CXR, an AI-based system for detecting tuberculosis (TB) from chest X-rays. A total of 1,000 retrospective CXR cases from the hospital’s PACS archive will be analyzed, including both TB-positive and TB-negative patients. Reference standards will include confirmatory tests such as High-Resolution CT (HRCT), nucleic acid amplification tests (NAAT), and documented clinical diagnoses. The primary objective is to determine the sensitivity, specificity, positive predictive value, negative predictive value, and area under the ROC curve (AUC) for Active TB detection. All AI misclassifications will be reviewed by a radiologist and clinical team to identify error patterns, and findings will be used for iterative AI model refinement. The study’s outcomes will inform the integration of AI into real-world TB screening workflows to improve diagnostic accuracy and public health impact. 
Close